Read the room.
L4P isn’t being left to chance.
It’s being propped up by some of the company’s most experienced teams: IADs, FRMs, and the HIV Expansion team.
Why?
Because Gilead can’t afford for it to fail.
This isn’t just a product launch, it’s a market shift. Gilead isn’t gonna risk a fumble on an entry-level Expansion Team.
The quicker the Expansion Team converts new adopters, the better the downstream impact—for PrEP reps, for L4P Brand equity & for Gilead’s revenue.
This is a business-critical initiative. And that’s exactly why it’s being fortified with top-tier talent.